Metastasis formation is the main cause of cancer-related death in patients with solid
tumours. At the beginning of this process, cancer cells escape from the primary tumour to the …

The practice of “liquid biopsy” as a diagnostic, prognostic and theranostic tool in non-small
cell lung cancer (NSCLC) patients is an appealing approach, at least in theory, since it is …

Chronic obstructive pulmonary disease (COPD) is a risk factor for lung cancer. Migration of
circulating tumor cells (CTCs) into the blood stream is an early event that occurs during …

Background: Circulating tumour cells (CTCs) can provide information on patient prognosis
and treatment efficacy. However, there is no universal method to detect CTC currently …

The isolation of circulating tumor cells (CTCs) from the blood of patients afflicted with solid
malignant tumors becomes increasingly important as it may serve as a 'liquid biopsy'with the …

Circulating tumor cells (CTCs) are rare cancer cells released from tumors into the
bloodstream that are thought to have a key role in cancer metastasis. The presence of CTCs …

Efforts to improve the clinical management of several cancers include finding better methods
for the quantitative and qualitative analysis of circulating tumor cells (CTCs). However …

Unmet needs in prostate cancer drug development and patient management are the ability
to monitor treatment effects and to identify therapeutic targets in a tumor at the time treatment …

A variety of filters assays have been described to enrich circulating tumor cells (CTC) based
on differences in physical characteristics of blood cells and CTC. In this study we evaluate …

The metastatic dissemination and spread of malignant circulating tumor cells (CTCs)
accounts for more than 90% of cancer-related deaths. CTCs detach from a primary tumor …